Novo Nordisk CEO to step down as Wegovy maker faces growing competition
found
The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post "for a period to support a smooth transition to new leadership."
You are not logged in so some information on this page has been withheld. To see more, please log in.